Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
0.00%
)
US TECH 100
23,588.00
(
-0.87%
)
Dow Jones
46,225.15
(
0.00%
)
Brent Oil
107.83
(
1.17%
)
Bitcoin
69,250.72
(
-2.79%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 203138

Wednesday, 08/24/2016 4:44:54 PM

Wednesday, August 24, 2016 4:44:54 PM

Post# of 257257
MNTA closes +11% on positive news from USPTO wrt 40mg Copaxone:

#msg-124747494
#msg-124748552

In short, two of TEVA’s three 40mg-Copaxone patents at issue in the IPR have been invalidated, and we’re still waiting for news from the PTO on the third (very similar) patent.

For background info on the 40mg-Copaxone patent case in US District Court (which is separate from the IPR), please see #msg-124628031.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now